STERIS plc (Ireland) ($STE) Stock Forecast: Up 2.2% Today

What is STERIS plc (Ireland)?

STERIS plc (STE) is a healthcare company specializing in infection prevention, sterilization, and endoscopy products crucial for hospitals. The company reported strong Q3 earnings, beating analyst estimates, and maintains a consensus "Moderate Buy" rating with an average price target of $273.50. Despite insider selling, institutional investors own a significant portion of the company's stock.

Why is STERIS plc (Ireland) going up?

STE stock is up 2.2% on Jan 5, 2026 17:25

• Harvey Investment Co. LLC increasing its stake in STERIS plc by 17.1% indicates confidence in the company's future growth prospects, contributing to the bullish movement.
• The positive sentiment from analysts and institutional investors, coupled with STERIS exceeding earnings estimates and providing strong guidance, likely boosted investor confidence in the stock.
• While Pacer Advisors Inc. reducing its stake may have initially caused some selling pressure, the overall market sentiment remained positive due to the company's solid financial performance and essential services in the healthcare sector.
• STERIS's stability and long-term growth potential positioned the stock as an attractive option for investors seeking reliability amidst market volatility, further supporting its bullish movement.

STE Price Chart

STE Technical Analysis

STE News

Harvey Investment Co. LLC Raises Position in STERIS plc $STE

Harvey Investment Co. LLC increased its stake in STERIS plc (NYSE:STE) by 17.1% during the third quarter, making STERIS its 16th largest position and comprising approximately 2.5% of its holdings. STERIS reported strong Q3 earnings, beating analyst estimates with EPS of $2.47 and revenue of $1.46 billion, and maintains a consensus "Moderate Buy" rating with an average price target of $273.50. Despite insider selling, institutional investors own a significant 94.69% of the company's stock.

https://www.marketbeat.com/instant-alerts/filing-harvey-investment-co-llc-raises-position-in-steris-plc-ste-2026-01-05/

The Truth About STERIS plc: Why Wall Street Is Quietly Obsessed (And Why You Should Care)

STERIS plc (STE) is a healthcare giant specializing in infection prevention, sterilization, and endoscopy products crucial for hospitals. While not a social media sensation, its recurring revenue model and essential services make it a valuable long-term holding for investors seeking stability in the healthcare sector. The article advises that STE is a "cop" for patient investors valuing long-term growth over meme stock volatility.

https://www.ad-hoc-news.de/boerse/news/ueberblick/the-truth-about-steris-plc-why-wall-street-is-quietly-obsessed-and-why/68459857

STERIS plc (NYSE:STE) Given Average Recommendation of "Moderate Buy" by Analysts

STERIS plc (NYSE:STE) has received an average "Moderate Buy" rating from nine analysts, with a 12-month average target price of $273.50. The medical equipment provider recently surpassed quarterly earnings estimates and announced a quarterly dividend, setting its FY 2026 EPS guidance between $10.150 and $10.30. Insider transactions show recent stock sales by company executives, while institutional investors have been modifying their holdings in the firm.

https://www.marketbeat.com/instant-alerts/steris-plc-nyseste-given-average-recommendation-of-moderate-buy-by-analysts-2026-01-03/

Ethic Inc. Has $2.07 Million Stake in STERIS plc $STE

Ethic Inc. significantly increased its stake in STERIS plc (NYSE:STE) by 388.2% in Q3, now holding 8,378 shares valued at approximately $2.07 million. This comes as STERIS exceeded Q3 earnings and revenue estimates, providing positive FY2026 guidance. Institutional investors hold a large portion of the stock, while company insiders have recently sold shares.

https://www.marketbeat.com/instant-alerts/filing-ethic-inc-has-207-million-stake-in-steris-plc-ste-2026-01-02/

STERIS plc $STE Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in STERIS plc (NYSE:STE) by 41.7% in the third quarter, selling 5,950 shares and holding 8,320 shares valued at $2,059,000. Despite this, other hedge funds like Norges Bank and Orbis Allan Gray Ltd increased their positions, indicating mixed institutional investor sentiment. STERIS reported strong earnings, beating analyst estimates, and has a "Moderate Buy" average rating from Wall Street analysts.

https://www.marketbeat.com/instant-alerts/filing-steris-plc-ste-shares-sold-by-pacer-advisors-inc-2026-01-01/

Trending Today

Uniswap ($UNI) Crypto Forecast: Down 5.6% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.2% Today

Paysafe Limited ($PSFE) Stock Forecast: Down 5.2% Today

Amcor plc ($AMCR) Stock Forecast: Up 401.1% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Up 7.0% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Down 6.5% Today

KLA-Tencor Corporation ($KLAC) Stock Forecast: Up 8.7% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 5.4% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Down 5.1% Today

BlackRock Inc. ($BLK) Stock Forecast: Up 6.7% Today

STERIS plc (Ireland) Price History

15.04.2025 - STE Stock was up 8.7%

• STE exceeded Q4 earnings expectations, with increased margins, leading to a rise in the stock price.
• The strong growth in Healthcare and AST revenues played a crucial role in the market's positive response.
• Beating earnings estimates by a notable margin and surprising revenue figures indicated the company's strong performance and potential growth.
• Positive analyst projections and key metrics for STE's Q4 earnings reinforced investor confidence in the stock.

15.04.2025 - STE Stock was up 5.2%

• Steris (STE) outperformed earnings expectations in the fourth quarter, demonstrating robust financial performance.
• Projections from analysts on key metrics suggest a positive trajectory for Steris, bolstering investor confidence.
• Strong financial results exceeding estimates and optimistic analyst forecasts likely fueled today's bullish movement in Steris (STE) stock.
• The company’s solid performance and growth potential may be prompting investors to increase buying activity, consequently driving up the stock price.

07.07.2025 - STE Stock was up 5.9%

• Steris (STE) reported better-than-expected Q1 earnings and revenue, indicating strong financial performance.
• The announcement of a new Chief Financial Officer may have instilled confidence in investors about the company's future leadership and strategic direction.
• Analysts are optimistic about Steris' key performance measures, particularly in the Healthcare and Applied Sterilization Technologies segments, which are expected to drive growth.
• The focus on Healthcare growth and anticipated EPS growth of 14.3% further bolstered investor sentiment, contributing to the bullish movement in the stock price.

07.07.2025 - STE Stock was up 6.5%

• STE experienced a strong bullish movement today, likely in response to the positive Q1 earnings performance.
• The company exceeded both earnings and revenue expectations, showcasing a 15% growth in EPS and an upgraded FY26 revenue projection.
• The recent appointment of a new Chief Financial Officer may have also influenced investor sentiment in a favorable manner.
• Analysts hold an optimistic outlook on STE, particularly in the healthcare industry, foreseeing continued growth and the possibility of more positive earnings surprises in the future.

07.10.2024 - STE Stock was down 6.1%

• Despite surpassing earnings expectations in Q2, STE observed a downward trend in its stock price, possibly influenced by worries about margin reduction.
• The market's negative response to the margin decline contrasts with the solid revenue expansion in the Healthcare and AST segments.
• Investor sentiment towards the company's outlook appears cautious, as indicated by queries about future stock performance.

07.10.2024 - STE Stock was down 5.0%

• Following an exceedance of Q2 earnings forecasts, Steris encountered a decline in its stock value.
• Market participants potentially anticipated greater company performance or outlook.
• Any apprehensions or uncertainties voiced during the earnings call might have elicited a negative market response.
• Traders could be engaging in profit-taking subsequent to a period of pre-earnings growth.

09.04.2024 - STE Stock was up 6.9%

• The company reported a loss in its fiscal Q4 earnings, aligning with earnings estimates.
• Despite the reported loss, the stock displayed a bullish movement, suggesting investor focus may be on other positive aspects of the company.
• The company was downgraded from a "buy" rating to a "hold" rating by an analyst platform, which typically impacts the stock negatively. However, the market movement remained bullish.
• Investor optimism regarding Steris' competitive strengths and financial metrics could be contributing to the bullish movement despite the mixed earnings report.

09.06.2024 - STE Stock was down 2.5%

• The current downward trend in STE stock may stem from investor wariness of broader economic challenges.
• Although the AST segment shows strong recovery potential, general economic uncertainties could be outweighing positive outlook.
• Investors appear to be adopting a cautious stance, analyzing the interplay between STE's business strengths and external economic conditions.

28.09.2025 - STE Stock was down 1.4%

• The decline in STE stock today could be linked to the following factors:
• Investor caution ahead of the upcoming Q2 earnings.
• Potential apprehensions about the company's performance in the current quarter.
• The market reacting to the announcement of a conference call to review fiscal 2026 second quarter results.

07.07.2024 - STE Stock was down 0.4%

• Despite surpassing expectations in earnings and revenue for the first quarter of fiscal 2025, Steris (STE) witnessed a significant downward trend in the market.
• The company's impressive financial results and revenue growth, especially in the healthcare sector, could not counteract the negative impact on its stock.
• The bearish movement in STE stock might have been influenced by shareholders' support for board and auditor proposals, which could have been overshadowed by external market conditions or other unrelated concerns.
• The decline in Steris (STE) stock value could be a result of investors' reactions to external elements or uncertainties ahead, despite the company's robust financial performance.

06.10.2025 - STE Stock was up 6.6%

• STE stock saw significant bullish activity today.
• Surpassing Q2 earnings and revenue projections signals robust financial results for the company.
• A noteworthy 10% rise in total revenue for the second quarter of fiscal 2026 highlights favorable growth prospects.
• Positive sentiments from analysts and investors regarding STE's future performance are bolstering investor trust in the stock.

05.00.2026 - STE Stock was up 2.2%

• Harvey Investment Co. LLC increasing its stake in STERIS plc by 17.1% indicates confidence in the company's future growth prospects, contributing to the bullish movement.
• The positive sentiment from analysts and institutional investors, coupled with STERIS exceeding earnings estimates and providing strong guidance, likely boosted investor confidence in the stock.
• While Pacer Advisors Inc. reducing its stake may have initially caused some selling pressure, the overall market sentiment remained positive due to the company's solid financial performance and essential services in the healthcare sector.
• STERIS's stability and long-term growth potential positioned the stock as an attractive option for investors seeking reliability amidst market volatility, further supporting its bullish movement.